These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26833872)

  • 1. Editorial Comment to Association between levels of urinary heavy metals and increased risk of urothelial carcinoma.
    Golabek T; Bukowczan J
    Int J Urol; 2016 Mar; 23(3):240. PubMed ID: 26833872
    [No Abstract]   [Full Text] [Related]  

  • 2. Association between levels of urinary heavy metals and increased risk of urothelial carcinoma.
    Chang CH; Liu CS; Liu HJ; Huang CP; Huang CY; Hsu HT; Liou SH; Chung CJ
    Int J Urol; 2016 Mar; 23(3):233-9. PubMed ID: 26663353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial Comment to High neutrophil-to-lymphocyte ratio predicts worse overall survival in patients with advanced/metastatic urothelial bladder cancer.
    Ohno Y
    Int J Urol; 2018 Mar; 25(3):238-239. PubMed ID: 29216687
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial Comment from Dr Shiota to Stage and cancer-specific mortality differ within specific Asian ethnic groups for upper tract urothelial carcinoma: North American population-based study.
    Shiota M
    Int J Urol; 2021 Dec; 28(12):1253. PubMed ID: 34545645
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial Comment from Dr Lonati and Dr Moschini to Stage and cancer-specific mortality differ within specific Asian ethnic groups in upper tract urothelial carcinoma: North American population-based study.
    Lonati C; Moschini M
    Int J Urol; 2021 Dec; 28(12):1252-1253. PubMed ID: 34580928
    [No Abstract]   [Full Text] [Related]  

  • 6. EDITORIAL COMMENT.
    Lee BH
    Urology; 2019 Nov; 133():161-162. PubMed ID: 31706415
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial Comment on Plasmacytoid Variant Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-Analysis of Clinicopathological Features and Survival Outcomes.
    Mehrazin R
    J Urol; 2020 Sep; 204(3):413. PubMed ID: 32762316
    [No Abstract]   [Full Text] [Related]  

  • 8. Urothelial cancer of the urinary bladder: can lessons learned be applied to the upper urinary tract?
    Krabbe LM; Hutchinson RC; Margulis V
    Minerva Urol Nefrol; 2016 Aug; 68(4):396-408. PubMed ID: 26990295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial Comment to Effect of preoperative chemotherapy on survival of patients with upper urinary tract urothelial carcinoma clinically involving regional lymph nodes.
    Urakami S; Okaneya T
    Int J Urol; 2016 Feb; 23(2):158-9. PubMed ID: 26663568
    [No Abstract]   [Full Text] [Related]  

  • 10. Towards the future of upper tract urothelial carcinoma surveillance: lessons learnt from bladder cancer urinary biomarkers.
    Gallioli A; Boissier R; Territo A; Breda A
    World J Urol; 2019 Sep; 37(9):1985-1986. PubMed ID: 30600353
    [No Abstract]   [Full Text] [Related]  

  • 11. Bending the Curve of Advanced Urothelial Carcinoma.
    Geynisman DM; Plimack ER
    J Oncol Pract; 2017 May; 13(5):319-320. PubMed ID: 28489979
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemoimmunotherapy in Metastatic Urothelial Carcinoma.
    Geynisman DM; Abbosh PH; Plimack ER; Zibelman M
    Eur Urol; 2018 May; 73(5):760-762. PubMed ID: 29331216
    [No Abstract]   [Full Text] [Related]  

  • 13. Bladder cancer: uPAR expression indicates worse prognosis of urothelial carcinoma.
    Sidaway P
    Nat Rev Urol; 2015 Mar; 12(3):120. PubMed ID: 25644167
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of Urothelial Bladder Cancer: Predicting the Future.
    Stadler WM
    J Oncol Pract; 2019 Aug; 15(8):429-430. PubMed ID: 31404513
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: HER2 as a Target in Invasive Urothelial Carcinoma.
    Chang SS
    J Urol; 2016 Dec; 196(6):1637-1639. PubMed ID: 27845103
    [No Abstract]   [Full Text] [Related]  

  • 16. Bladder cancer: Targeted agents reverse chemotherapy resistance in urothelial carcinoma.
    Sidaway P
    Nat Rev Urol; 2016 Sep; 13(9):494. PubMed ID: 27480945
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial Comment from Dr Defidio to Thulium laser ablation facilitates retrograde intra-renal surgery for upper urinary tract urothelial carcinoma.
    Defidio L
    Int J Urol; 2018 Apr; 25(4):381-382. PubMed ID: 29577441
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial Comment from Dr Castelli to Thulium laser ablation facilitates retrograde intra-renal surgery for upper urinary tract urothelial carcinoma.
    Castelli E
    Int J Urol; 2018 Apr; 25(4):380-381. PubMed ID: 29520838
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma.
    Black PC; Seiler R
    Eur Urol; 2016 Dec; 70(6):1076. PubMed ID: 27567209
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunomodulatory treatment in urothelial cancer.
    Dreicer R
    Lancet Oncol; 2016 Nov; 17(11):1475-1477. PubMed ID: 27733242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.